General Information |
| Board Constituency: |
Developing Country NGO |
| Organization Type - Primary: |
Non-Governmental Organization |
| Organization Type - Secondary: |
Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
National |
| Organization Description: |
Human Rights Research & Development Center initiative TB/HIV research and clinic care department was set up to look at all available evidence in the literature and in a variety of settings in the attempt to produce guidance for national programmes on how to engage effectively their people and communities in the fi ght against TB. The document we are now ready to disseminate is indeed the result of a fully participatory process right from case studies at communities and country level, up to the creation of a task force with all relevant constituencies represented, a wide internet consultation, and, fi nally, an inclusive writing committee. The fi nal guidance document focuses on a few essential needs. First, it is essential to build and sustain the motivation of all actors involved: such motivation and rationale for action are rooted in a human right-based approach and principles of social justice. The attempt here is to reverse a widespread approach whereby the issue of motivation is often raised when problems of sustainability occur and not at the very beginning of an initiative. Second, the guidance document addresses the methodological issue of how to initiate and promote community participation and involvement. This methodology is necessarily and substantially based on the same principles of social justice, which is the guiding aim of every effort in pursuing better health for all.HRRDC TB/HIV research clinic department is to improve access to effective TB treatment, the Human Rights Research & Development Center observed that TB is very complex to treat, requiring a combination of daily drugs over a half-year treatment period. In order to avoid resistances over the long treatment period, the WHO recommends Directly Observed Treatment Short-course (DOTS), requiring patients to take their drugs under daily observation of a healthcare professional. Although DOTS ensures better patient adherence, it poses a burden on both providers and patients: Already overstrained healthcare personnel face an inc |
| |
| Total number of staff in your organization: |
11 - 25 |
| Number of full-time staff who are directly involved with TB: |
6 - 10 |
| Number of part-time staff who are directly involved with TB: |
1 - 5 |
| Number of volunteers who are directly involved with TB: |
6 - 10 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$10,001-$25,000 |
| How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: |
Involvement in Stop TB Working Groups |
| |
| Are you a member of a Stop TB national partnership: |
Nigeria |
| Are you in contact with your national TB programme: |
No |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| ADVOCACY PROGRAM,SEMINARS CONFERENCES RESEARCH AND INVOLVEMENT OF TB CONTROL PLAN. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
Nigeria |
| Which WHO region is the main focus of your work: |
African |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Nigeria |